| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT07637578 A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory… |
Recruitment opened |
| 2026-08-04 | NCT07637578 A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory… |
Trial sites expanded: 0 -> 3 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05748834 | Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor… | Breast Cancer | Recruiting |
| NCT05972135 | Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT06773910 | BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer… | Limited Stage Small Cell Lung Cancer | Recruiting |
| NCT06974786 | Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable… | Multiple Myeloma, Newly Diagnosed | Recruiting |
| NCT07011576 | A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With… | Colon Cancer | Recruiting |
| NCT07637578 | A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory… | Multiple Myeloma (MM) | Recruiting |